Use of an active substance in the treatment of melasma
OwnerDoris Maria Hexselinventor
Life of this patent
Estimating the term…
Abstract
The present invention belongs, in a general manner to the technological field of the pharmaceutical industry and relates, more specifically, to one or more compositions of second use to be destined for the treatment of melasma. The present invention relates to the use of substances belonging to the group of alpha-adrenergic receptor agonists, in different variable concentrations, for treating conditions of melasma upon human skin. Furthermore, the present invention discloses pharmaceutical compositions, the latter being associated or not with other compounds or methods of treatment, to be utilised for the treatment of melasma.
Claims9
A method of Use of a pharmaceutical composition comprising an active substance of the group of alpha-adrenergic receptor agonists, comprising the step of applying the composition to a skin lesions of melasma.
Dependencies are inferred from the claim text.